Susan Burwig Biography and Net Worth

VP of Medpace


Susan E. Burwig serves as Executive Vice President - Operations of the Company. She joined Medpace in August 1993 and has served in various key leadership roles within the Clinical Operations department. From February 2003 to May 2015, Ms. Burwig served as Senior Vice President, Clinical Operations, overseeing clinical trial management, clinical monitoring, start-up, including feasibility, and new business proposals. In June 2015, Ms. Burwig was appointed Senior Vice President, Operations, and in January 2017 she was named as Executive Vice President, Operations. Prior to joining Medpace, Ms. Burwig held several clinical roles, including leading heart failure clinical research studies at the University of Cincinnati. Ms. Burwig received her Bachelor of Science in Nursing as well as an MA in Sports Administration from Kent State University.

What is Susan E. Burwig's net worth?

The estimated net worth of Susan E. Burwig is at least $5.65 million as of March 15th, 2024. Ms. Burwig owns 15,181 shares of Medpace stock worth more than $5,647,332 as of April 19th. This net worth approximation does not reflect any other investments that Ms. Burwig may own. Additionally, Ms. Burwig receives a salary of $1,000,000.00 as VP at Medpace. Learn More about Susan E. Burwig's net worth.

How old is Susan E. Burwig?

Ms. Burwig is currently 61 years old. There are 5 older executives and no younger executives at Medpace. The oldest executive at Medpace is Dr. August James Troendle M.D., Chairman & CEO, who is 68 years old. Learn More on Susan E. Burwig's age.

What is Susan E. Burwig's salary?

As the VP of Medpace Holdings, Inc., Ms. Burwig earns $1,000,000.00 per year. The highest earning executive at Medpace is Dr. August James Troendle M.D., Chairman & CEO, who commands a salary of $1,680,000.00 per year. Learn More on Susan E. Burwig's salary.

How do I contact Susan E. Burwig?

The corporate mailing address for Ms. Burwig and other Medpace executives is 5375 MEDPACE WAY, CINCINNATI OH, 45227. Medpace can also be reached via phone at (513) 579-9911 and via email at [email protected]. Learn More on Susan E. Burwig's contact information.

Has Susan E. Burwig been buying or selling shares of Medpace?

Susan E. Burwig has not been actively trading shares of Medpace in the last ninety days. Most recently, Susan E. Burwig sold 102 shares of the business's stock in a transaction on Friday, March 15th. The shares were sold at an average price of $403.00, for a transaction totalling $41,106.00. Following the completion of the sale, the vice president now directly owns 15,181 shares of the company's stock, valued at $6,117,943. Learn More on Susan E. Burwig's trading history.

Who are Medpace's active insiders?

Medpace's insider roster includes Kevin Brady (CFO), Susan Burwig (VP), Stephen Ewald (General Counsel), Jesse Geiger (CFO), Ashley Keating (Director), Tom King (Director), Robert Kraft (Director), and August Troendle (CEO). Learn More on Medpace's active insiders.

Are insiders buying or selling shares of Medpace?

In the last twelve months, insiders at the sold shares 25 times. They sold a total of 841,430 shares worth more than $246,456,813.05. The most recent insider tranaction occured on March, 15th when VP Susan E Burwig sold 102 shares worth more than $41,106.00. Insiders at Medpace own 20.3% of the company. Learn More about insider trades at Medpace.

Information on this page was last updated on 3/15/2024.

Susan E. Burwig Insider Trading History at Medpace

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/15/2024Sell102$403.00$41,106.0015,181View SEC Filing Icon  
12/14/2023Sell10,391$304.15$3,160,422.6517,292View SEC Filing Icon  
6/14/2021Sell15,000$178.96$2,684,400.0077,405View SEC Filing Icon  
7/30/2020Sell6,000$121.14$726,840.0046,179View SEC Filing Icon  
8/17/2016Buy19,211$29.21$561,153.311,211View SEC Filing Icon  
See Full Table

Susan E. Burwig Buying and Selling Activity at Medpace

This chart shows Susan E Burwig's buying and selling at Medpace by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Medpace Company Overview

Medpace logo
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Read More

Today's Range

Now: $372.00
Low: $368.37
High: $377.86

50 Day Range

MA: $395.78
Low: $324.21
High: $413.31

2 Week Range

Now: $372.00
Low: $185.43
High: $419.42

Volume

221,633 shs

Average Volume

240,371 shs

Market Capitalization

$11.52 billion

P/E Ratio

41.89

Dividend Yield

N/A

Beta

1.38